SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-014214
Filing Date
2019-05-20
Accepted
2019-05-20 18:32:40
Documents
1
Period of Report
2019-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12915
  Complete submission text file 0000899243-19-014214.txt   14997
Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800
QVT Associates GP LLC (Reporting) CIK: 0001290166 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38667 | Film No.: 19840364

Mailing Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617
Business Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Issuer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 190 ELGIN AVENUE GEORGE TOWN E9 KY1-9005
Business Address 190 ELGIN AVENUE GEORGE TOWN E9 KY1-9005 2127058888
QVT Financial Investment Cayman Ltd. (Reporting) CIK: 0001771138 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38667 | Film No.: 19840365